EUVIMEDEUVIMED entdecken
Open Access

Mitochondrial CypD Acetylation Promotes Endothelial Dysfunction and Hypertension

Anna Dikalova, Daniel Fehrenbach iD, Vladimir Mayorov, Alexander Panov, Mingfang Ao, Louise Lantier iD, Venkataraman Amarnath, Marcos G Lopez, Frederic T Billings, Michael N Sack iD, Sergey Dikalov iD

Circulation Research · 2024

DOI: 10.1161/circresaha.123.323596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, 2024. Verfasst von Anna Dikalova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, TN (A.D., D.F., M.A., V.A., M.G.L., F.T.B.I., S.D.). Hauptthemen laut MEDLINE: Endothelium, Vascular, Hypertension, Mitochondria, Sirtuin 3. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Nearly half of adults have hypertension, a major risk factor for cardiovascular disease. Mitochondrial hyperacetylation is linked to hypertension, but the role of acetylation of specific proteins is not clear. We hypothesized that acetylation of mitochondrial CypD (cyclophilin D) at K166 contributes to endothelial dysfunction and hypertension. METHODS: To test this hypothesis, we studied CypD acetylation in patients with essential hypertension, defined a pathogenic role of CypD acetylation in deacetylation mimetic CypD-K166R mutant mice and endothelial-specific GCN5L1 (general control of amino acid synthesis 5 like 1)–deficient mice using an Ang II (angiotensin II) model of hypertension. RESULTS: Arterioles from hypertensive patients had 280% higher CypD acetylation coupled with reduced Sirt3 (sirtuin 3) and increased GCN5L1 levels. GCN5L1 regulates mitochondrial protein acetylation and promotes CypD acetylation, which is counteracted by mitochondrial deacetylase Sirt3. In human aortic endothelial cells, GCN5L1 depletion prevents superoxide overproduction. Deacetylation mimetic CypD-K166R mice were protected from vascular oxidative stress, endothelial dysfunction, and Ang II-induced hypertension. Ang II-induced hypertension increased mitochondrial GCN5L1 and reduced Sirt3 levels resulting in a 250% increase in GCN5L1/Sirt3 ratio promoting CypD acetylation. Treatment with mitochondria-targeted scavenger of cytotoxic isolevuglandins (mito2HOBA) normalized GCN5L1/Sirt3 ratio, reduced CypD acetylation, and attenuated hypertension. The role of mitochondrial acetyltransferase GCN5L1 in the endothelial function was tested in endothelial-specific GCN5L1 knockout mice. Depletion of endothelial GCN5L1 prevented Ang II-induced mitochondrial oxidative stress, reduced the maladaptive switch of vascular metabolism to glycolysis, prevented inactivation of endothelial nitric oxide, preserved endothelial-dependent relaxation, and attenuated hypertension. CONCLUSIONS: These data support the pathogenic role of CypD acetylation in endothelial dysfunction and hypertension. We suggest that targeting cytotoxic mitochondrial isolevuglandins and GCN5L1 reduces CypD acetylation, which may be beneficial in cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelium, VascularHypertensionMitochondriaSirtuin 3AnimalsFemaleHumansMaleMiceAcetylationAngiotensin IICells, CulturedEndothelial CellsMice, Inbred C57BLMice, KnockoutMitochondrial ProteinsNerve Tissue ProteinsOxidative StressPeptidyl-Prolyl Isomerase F

Stichwörter der Autor:innen

blood pressurecardiovascular diseaseshypertensionmitochondriasuperoxides

Substanzen

Angiotensin IIMitochondrial ProteinsNerve Tissue ProteinsSirtuin 3BLOC1S1 protein, humanBLOC1S1 protein, mousePPIF protein, humanPeptidyl-Prolyl Isomerase FPPIF protein, mouse

Autor:innen und Institutionen

  • Vanderbilt University Medical Center, Nashville, TN (A.D., D.F., M.A., V.A., M.G.L., F.T.B.I., S.D.).
  • Mercer University School of Medicine, Macon, GA (V.M., A.P.).
  • Vanderbilt University, Nashville, TN (L.L.).
  • National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD (M.N.S.).

ORCID-Profile: Daniel Fehrenbach, Louise Lantier, Michael N Sack, Sergey Dikalov

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Dikalova, A., Fehrenbach, D., Mayorov, V., Panov, A., Ao, M., Lantier, L., Amarnath, V., Lopez, M. G., Billings, F. T., Sack, M. N., & Dikalov, S. (2024). Mitochondrial CypD Acetylation Promotes Endothelial Dysfunction and Hypertension. Circulation Research. https://doi.org/10.1161/circresaha.123.323596

Vancouver

Dikalova A, Fehrenbach D, Mayorov V, Panov A, Ao M, Lantier L, et al. Mitochondrial CypD Acetylation Promotes Endothelial Dysfunction and Hypertension. Circulation Research. 2024. doi:10.1161/circresaha.123.323596

BibTeX
@article{Dikalova2024,
  author = {Dikalova, Anna and Fehrenbach, Daniel and Mayorov, Vladimir and Panov, Alexander and Ao, Mingfang and Lantier, Louise and Amarnath, Venkataraman and Lopez, Marcos G and Billings, Frederic T and Sack, Michael N and Dikalov, Sergey},
  title = {Mitochondrial CypD Acetylation Promotes Endothelial Dysfunction and Hypertension},
  journal = {Circulation Research},
  year = {2024},
  doi = {10.1161/circresaha.123.323596}
}
Kostenlos starten →